Concepts (306)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ice | 7 | 2023 | 102 | 4.650 |
Why?
|
| Cryosurgery | 4 | 2023 | 468 | 1.490 |
Why?
|
| Cryotherapy | 4 | 2023 | 159 | 1.450 |
Why?
|
| Skin Diseases | 5 | 2023 | 1094 | 1.300 |
Why?
|
| Lipectomy | 3 | 2023 | 113 | 1.300 |
Why?
|
| Subcutaneous Fat | 4 | 2023 | 393 | 1.240 |
Why?
|
| Biomedical Technology | 2 | 2020 | 210 | 1.200 |
Why?
|
| Dermatology | 4 | 2024 | 918 | 1.170 |
Why?
|
| Transmembrane Activator and CAML Interactor Protein | 9 | 2016 | 55 | 0.920 |
Why?
|
| Analgesia | 2 | 2022 | 461 | 0.730 |
Why?
|
| Sciatic Nerve | 2 | 2022 | 618 | 0.700 |
Why?
|
| Acne Vulgaris | 2 | 2023 | 349 | 0.690 |
Why?
|
| Pruritus | 2 | 2013 | 378 | 0.660 |
Why?
|
| Body Temperature | 1 | 2022 | 780 | 0.640 |
Why?
|
| Adipose Tissue | 5 | 2023 | 3309 | 0.630 |
Why?
|
| Intra-Abdominal Fat | 1 | 2023 | 612 | 0.610 |
Why?
|
| Common Variable Immunodeficiency | 5 | 2010 | 101 | 0.550 |
Why?
|
| Neck | 1 | 2020 | 734 | 0.500 |
Why?
|
| Telemedicine | 2 | 2023 | 3050 | 0.480 |
Why?
|
| Biomedical Research | 3 | 2020 | 3426 | 0.480 |
Why?
|
| Needs Assessment | 1 | 2020 | 1139 | 0.460 |
Why?
|
| Sensory Thresholds | 1 | 2015 | 377 | 0.450 |
Why?
|
| Physicians | 2 | 2022 | 4583 | 0.440 |
Why?
|
| Nerve Block | 1 | 2020 | 705 | 0.430 |
Why?
|
| Hospitals, General | 1 | 2017 | 798 | 0.410 |
Why?
|
| Faculty, Medical | 2 | 2020 | 1204 | 0.410 |
Why?
|
| Cosmetic Techniques | 3 | 2024 | 148 | 0.400 |
Why?
|
| Curriculum | 2 | 2022 | 3738 | 0.390 |
Why?
|
| Skin Aging | 1 | 2013 | 140 | 0.380 |
Why?
|
| Sunlight | 2 | 2023 | 337 | 0.360 |
Why?
|
| Sensory Receptor Cells | 1 | 2015 | 508 | 0.350 |
Why?
|
| Skin Neoplasms | 6 | 2023 | 5812 | 0.330 |
Why?
|
| Ultraviolet Rays | 3 | 2023 | 1079 | 0.320 |
Why?
|
| Education, Medical | 1 | 2021 | 1724 | 0.320 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2013 | 328 | 0.320 |
Why?
|
| Myelin Sheath | 2 | 2022 | 653 | 0.290 |
Why?
|
| Weight Loss | 3 | 2023 | 2682 | 0.270 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2010 | 549 | 0.270 |
Why?
|
| Rats | 4 | 2023 | 23717 | 0.260 |
Why?
|
| Brachytherapy | 1 | 2013 | 1223 | 0.250 |
Why?
|
| Quality Improvement | 1 | 2020 | 3797 | 0.240 |
Why?
|
| Swine | 4 | 2023 | 5907 | 0.240 |
Why?
|
| Polymerase Chain Reaction | 2 | 2016 | 6074 | 0.240 |
Why?
|
| Obesity | 4 | 2023 | 12933 | 0.230 |
Why?
|
| Neurofibroma | 1 | 2023 | 95 | 0.220 |
Why?
|
| Animals | 20 | 2023 | 168201 | 0.210 |
Why?
|
| Neoplasm Metastasis | 1 | 2013 | 4910 | 0.200 |
Why?
|
| Freund's Adjuvant | 1 | 2022 | 145 | 0.200 |
Why?
|
| Sunscreening Agents | 1 | 2023 | 139 | 0.200 |
Why?
|
| Sunburn | 1 | 2023 | 156 | 0.200 |
Why?
|
| DNA-Directed RNA Polymerases | 2 | 2004 | 366 | 0.190 |
Why?
|
| Neuroma | 1 | 2023 | 133 | 0.190 |
Why?
|
| Skin | 1 | 2015 | 4473 | 0.190 |
Why?
|
| Paresthesia | 1 | 2022 | 162 | 0.190 |
Why?
|
| Cicatrix | 2 | 2023 | 785 | 0.180 |
Why?
|
| Esthetics | 1 | 2022 | 327 | 0.170 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2022 | 8166 | 0.170 |
Why?
|
| Chromosomes | 1 | 2003 | 578 | 0.170 |
Why?
|
| Melanoma | 4 | 2012 | 5697 | 0.170 |
Why?
|
| Pain | 3 | 2023 | 5061 | 0.160 |
Why?
|
| Temperature | 2 | 2022 | 2223 | 0.160 |
Why?
|
| Neurofibromatosis 1 | 1 | 2023 | 560 | 0.160 |
Why?
|
| Sus scrofa | 1 | 2020 | 428 | 0.160 |
Why?
|
| Injections, Subcutaneous | 1 | 2020 | 671 | 0.150 |
Why?
|
| B-Lymphocytes | 6 | 2011 | 4745 | 0.150 |
Why?
|
| Pain Measurement | 2 | 2020 | 3546 | 0.150 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 15498 | 0.140 |
Why?
|
| Injections | 1 | 2020 | 832 | 0.140 |
Why?
|
| Faculty | 1 | 2020 | 383 | 0.140 |
Why?
|
| Humans | 39 | 2024 | 760617 | 0.140 |
Why?
|
| DNA Repair | 2 | 2003 | 2043 | 0.140 |
Why?
|
| Adipocytes | 1 | 2023 | 1187 | 0.140 |
Why?
|
| IgA Deficiency | 2 | 2007 | 39 | 0.130 |
Why?
|
| Sentinel Lymph Node Biopsy | 2 | 2010 | 732 | 0.130 |
Why?
|
| Hot Temperature | 1 | 2022 | 1437 | 0.130 |
Why?
|
| Research Personnel | 1 | 2020 | 588 | 0.130 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 2016 | 130 | 0.120 |
Why?
|
| Sebaceous Glands | 1 | 2015 | 42 | 0.120 |
Why?
|
| Escherichia coli | 4 | 2004 | 4209 | 0.120 |
Why?
|
| Plasma Cells | 2 | 2009 | 597 | 0.120 |
Why?
|
| Hypersensitivity, Delayed | 1 | 2015 | 490 | 0.120 |
Why?
|
| Quality of Life | 2 | 2013 | 13347 | 0.120 |
Why?
|
| Lipolysis | 1 | 2015 | 211 | 0.110 |
Why?
|
| Models, Animal | 1 | 2020 | 2109 | 0.110 |
Why?
|
| Nephrogenic Fibrosing Dermopathy | 1 | 2013 | 42 | 0.110 |
Why?
|
| Haploinsufficiency | 2 | 2016 | 336 | 0.110 |
Why?
|
| Walking | 1 | 2020 | 1197 | 0.110 |
Why?
|
| Body Weight | 1 | 2023 | 4614 | 0.100 |
Why?
|
| Axons | 1 | 2020 | 1671 | 0.100 |
Why?
|
| Tumor Necrosis Factor Ligand Superfamily Member 13 | 2 | 2009 | 40 | 0.100 |
Why?
|
| Abdominal Fat | 1 | 2014 | 221 | 0.100 |
Why?
|
| Mice | 11 | 2023 | 81368 | 0.100 |
Why?
|
| Keratoacanthoma | 1 | 2012 | 33 | 0.100 |
Why?
|
| Interdisciplinary Communication | 1 | 2018 | 928 | 0.100 |
Why?
|
| Qualitative Research | 1 | 2022 | 3016 | 0.100 |
Why?
|
| Alopecia | 1 | 2016 | 412 | 0.100 |
Why?
|
| Combined Modality Therapy | 1 | 2023 | 8516 | 0.100 |
Why?
|
| Caveolin 1 | 1 | 2013 | 255 | 0.090 |
Why?
|
| Cold Temperature | 1 | 2015 | 784 | 0.090 |
Why?
|
| Physician's Role | 1 | 2018 | 917 | 0.090 |
Why?
|
| Photography | 1 | 2013 | 532 | 0.090 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2013 | 330 | 0.090 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2011 | 193 | 0.090 |
Why?
|
| Drug Discovery | 1 | 2018 | 1051 | 0.090 |
Why?
|
| Single-Blind Method | 1 | 2013 | 1575 | 0.090 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 2574 | 0.080 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2015 | 951 | 0.080 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2013 | 630 | 0.080 |
Why?
|
| Pilot Projects | 2 | 2020 | 8618 | 0.080 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 1970 | 0.080 |
Why?
|
| Prostheses and Implants | 1 | 2015 | 1269 | 0.080 |
Why?
|
| Mutant Proteins | 1 | 2010 | 489 | 0.080 |
Why?
|
| Drug Eruptions | 1 | 2012 | 335 | 0.080 |
Why?
|
| Amino Acid Substitution | 3 | 2009 | 1739 | 0.080 |
Why?
|
| Mutation, Missense | 2 | 2009 | 2570 | 0.080 |
Why?
|
| Antibody Formation | 2 | 2010 | 1390 | 0.070 |
Why?
|
| Immunohistochemistry | 3 | 2015 | 11069 | 0.070 |
Why?
|
| Students, Medical | 1 | 2020 | 1934 | 0.070 |
Why?
|
| Lymphocyte Activation | 3 | 2016 | 5463 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2015 | 6224 | 0.070 |
Why?
|
| Dermatitis | 1 | 2008 | 202 | 0.070 |
Why?
|
| Surgical Wound Infection | 1 | 2015 | 1529 | 0.070 |
Why?
|
| Ligands | 3 | 2009 | 3268 | 0.070 |
Why?
|
| Heterozygote | 2 | 2016 | 2780 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2003 | 9586 | 0.060 |
Why?
|
| Societies, Medical | 1 | 2018 | 3900 | 0.060 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2009 | 578 | 0.060 |
Why?
|
| Photochemotherapy | 1 | 2012 | 823 | 0.060 |
Why?
|
| Health Services Needs and Demand | 1 | 2013 | 1400 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2023 | 64568 | 0.060 |
Why?
|
| Male | 11 | 2020 | 360358 | 0.060 |
Why?
|
| Patient Satisfaction | 2 | 2016 | 3451 | 0.060 |
Why?
|
| Radiation Dosage | 1 | 2013 | 1956 | 0.060 |
Why?
|
| Point Mutation | 2 | 2007 | 1595 | 0.060 |
Why?
|
| Deinococcus | 1 | 2004 | 6 | 0.060 |
Why?
|
| Lymph Nodes | 3 | 2010 | 3461 | 0.060 |
Why?
|
| Massachusetts | 1 | 2017 | 8833 | 0.060 |
Why?
|
| Deoxycholic Acid | 1 | 2023 | 53 | 0.060 |
Why?
|
| 2-Aminopurine | 1 | 2003 | 11 | 0.060 |
Why?
|
| Indoles | 1 | 2012 | 1830 | 0.060 |
Why?
|
| MutS DNA Mismatch-Binding Protein | 1 | 2003 | 10 | 0.060 |
Why?
|
| Ethyl Methanesulfonate | 1 | 2003 | 29 | 0.060 |
Why?
|
| Mutagens | 1 | 2004 | 179 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 18221 | 0.050 |
Why?
|
| Mutation | 3 | 2010 | 30016 | 0.050 |
Why?
|
| Nucleoside-Diphosphate Kinase | 1 | 2002 | 17 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2005 | 581 | 0.050 |
Why?
|
| Pyrophosphatases | 1 | 2003 | 142 | 0.050 |
Why?
|
| Base Pair Mismatch | 1 | 2002 | 92 | 0.050 |
Why?
|
| Antibiotics, Antitubercular | 1 | 2003 | 99 | 0.050 |
Why?
|
| Sulfonamides | 1 | 2012 | 1977 | 0.050 |
Why?
|
| Signal Transduction | 3 | 2011 | 23416 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 1 | 2013 | 4739 | 0.050 |
Why?
|
| Binding, Competitive | 1 | 2003 | 1141 | 0.050 |
Why?
|
| Azacitidine | 1 | 2003 | 335 | 0.050 |
Why?
|
| Neoplasm Staging | 3 | 2012 | 11116 | 0.050 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2003 | 412 | 0.050 |
Why?
|
| Rifampin | 1 | 2003 | 339 | 0.050 |
Why?
|
| Multiprotein Complexes | 1 | 2007 | 1118 | 0.040 |
Why?
|
| Trinitrobenzenes | 2 | 2010 | 45 | 0.040 |
Why?
|
| Frameshift Mutation | 1 | 2002 | 392 | 0.040 |
Why?
|
| Ficoll | 2 | 2010 | 39 | 0.040 |
Why?
|
| Female | 10 | 2020 | 392148 | 0.040 |
Why?
|
| Immunoglobulins | 3 | 2009 | 850 | 0.040 |
Why?
|
| Genes, Viral | 1 | 2001 | 649 | 0.040 |
Why?
|
| Internship and Residency | 1 | 2020 | 5878 | 0.040 |
Why?
|
| Cross-Linking Reagents | 1 | 2003 | 685 | 0.040 |
Why?
|
| Herpesvirus 8, Human | 1 | 2001 | 255 | 0.040 |
Why?
|
| Biopsy, Needle | 2 | 2015 | 1624 | 0.040 |
Why?
|
| Transfection | 1 | 2007 | 5766 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 26049 | 0.040 |
Why?
|
| Hypersensitivity | 1 | 2008 | 1167 | 0.040 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2001 | 433 | 0.040 |
Why?
|
| Adenosine Triphosphatases | 1 | 2003 | 835 | 0.040 |
Why?
|
| Immediate-Early Proteins | 1 | 2001 | 444 | 0.040 |
Why?
|
| Hyaluronic Acid | 1 | 2022 | 483 | 0.040 |
Why?
|
| Palliative Care | 1 | 2013 | 3592 | 0.040 |
Why?
|
| Amino Acid Sequence | 2 | 2007 | 13441 | 0.040 |
Why?
|
| Cell Differentiation | 3 | 2011 | 11514 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2015 | 12943 | 0.040 |
Why?
|
| Prognosis | 3 | 2013 | 29600 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 6520 | 0.040 |
Why?
|
| Molecular Sequence Data | 2 | 2007 | 17629 | 0.030 |
Why?
|
| Cisplatin | 1 | 2003 | 1650 | 0.030 |
Why?
|
| Middle Aged | 4 | 2015 | 220584 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2007 | 4242 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 3 | 2011 | 6188 | 0.030 |
Why?
|
| Anti-Obesity Agents | 1 | 2019 | 227 | 0.030 |
Why?
|
| Prospective Studies | 3 | 2023 | 54360 | 0.030 |
Why?
|
| Escherichia coli Proteins | 1 | 2003 | 1064 | 0.030 |
Why?
|
| Age Factors | 1 | 2013 | 18381 | 0.030 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2003 | 1048 | 0.030 |
Why?
|
| Adult | 5 | 2023 | 220969 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2014 | 39063 | 0.030 |
Why?
|
| Cell Line | 2 | 2007 | 15576 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2001 | 1755 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2016 | 420 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 15828 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2013 | 9277 | 0.030 |
Why?
|
| Interleukin-4 | 2 | 2009 | 1146 | 0.030 |
Why?
|
| Viral Proteins | 1 | 2001 | 1799 | 0.030 |
Why?
|
| Phenotype | 3 | 2013 | 16571 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 15908 | 0.030 |
Why?
|
| Aged | 4 | 2013 | 169042 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 4 | 2016 | 22115 | 0.030 |
Why?
|
| Cytokines | 1 | 2008 | 7373 | 0.030 |
Why?
|
| Gene Frequency | 2 | 2013 | 3601 | 0.030 |
Why?
|
| Inflammation | 1 | 2013 | 10760 | 0.030 |
Why?
|
| Debridement | 1 | 2015 | 493 | 0.030 |
Why?
|
| Diffusion of Innovation | 1 | 2018 | 729 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2001 | 2852 | 0.020 |
Why?
|
| Codon | 1 | 2013 | 600 | 0.020 |
Why?
|
| Aminolevulinic Acid | 1 | 2012 | 144 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2016 | 1185 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2008 | 10175 | 0.020 |
Why?
|
| Device Removal | 1 | 2015 | 629 | 0.020 |
Why?
|
| Species Specificity | 1 | 2015 | 2411 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2014 | 1150 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2018 | 1504 | 0.020 |
Why?
|
| Introns | 1 | 2013 | 968 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2001 | 2985 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2001 | 5780 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2003 | 3842 | 0.020 |
Why?
|
| Cell Proliferation | 3 | 2010 | 10432 | 0.020 |
Why?
|
| Bariatric Surgery | 1 | 2019 | 992 | 0.020 |
Why?
|
| Mice, Knockout | 3 | 2009 | 14389 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 3800 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 2010 | 573 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 13635 | 0.020 |
Why?
|
| Communication | 1 | 2023 | 3849 | 0.020 |
Why?
|
| Androgens | 1 | 2016 | 1285 | 0.020 |
Why?
|
| Postoperative Complications | 3 | 2019 | 15612 | 0.020 |
Why?
|
| Rare Diseases | 1 | 2014 | 622 | 0.020 |
Why?
|
| Diagnostic Errors | 1 | 2015 | 1265 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2005 | 7847 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2001 | 4935 | 0.020 |
Why?
|
| Gadolinium | 1 | 2013 | 959 | 0.020 |
Why?
|
| B-Cell Maturation Antigen | 1 | 2009 | 149 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 58894 | 0.020 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2012 | 592 | 0.020 |
Why?
|
| Communicable Diseases | 1 | 2016 | 871 | 0.020 |
Why?
|
| Receptors, Cytokine | 1 | 2008 | 257 | 0.020 |
Why?
|
| Photosensitizing Agents | 1 | 2012 | 623 | 0.020 |
Why?
|
| DNA | 1 | 2001 | 7196 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2016 | 4269 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 3410 | 0.020 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2009 | 420 | 0.020 |
Why?
|
| Ovalbumin | 1 | 2008 | 675 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2022 | 7960 | 0.020 |
Why?
|
| Interferon Regulatory Factors | 1 | 2007 | 261 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2016 | 5863 | 0.020 |
Why?
|
| Fibrosis | 1 | 2013 | 2045 | 0.020 |
Why?
|
| Immunoglobulin A | 1 | 2009 | 978 | 0.020 |
Why?
|
| Cytidine Deaminase | 1 | 2007 | 243 | 0.020 |
Why?
|
| Disease Management | 1 | 2016 | 2506 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2015 | 5239 | 0.010 |
Why?
|
| Lymph Node Excision | 1 | 2010 | 1269 | 0.010 |
Why?
|
| Cells, Cultured | 2 | 2010 | 18937 | 0.010 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2004 | 335 | 0.010 |
Why?
|
| Dietary Supplements | 1 | 2016 | 3411 | 0.010 |
Why?
|
| Retrospective Studies | 3 | 2022 | 80566 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2013 | 22148 | 0.010 |
Why?
|
| Lac Operon | 1 | 2002 | 237 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2009 | 3792 | 0.010 |
Why?
|
| Spleen | 1 | 2008 | 2286 | 0.010 |
Why?
|
| Base Sequence | 2 | 2004 | 12421 | 0.010 |
Why?
|
| Clinical Trials as Topic | 2 | 2010 | 7995 | 0.010 |
Why?
|
| TATA Box | 1 | 2001 | 127 | 0.010 |
Why?
|
| Baculoviridae | 1 | 2001 | 115 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2009 | 2202 | 0.010 |
Why?
|
| Immunoglobulin E | 1 | 2007 | 1502 | 0.010 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2001 | 151 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2009 | 2481 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2015 | 12966 | 0.010 |
Why?
|
| Contrast Media | 1 | 2013 | 5305 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 12043 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2004 | 1490 | 0.010 |
Why?
|
| Multicenter Studies as Topic | 1 | 2004 | 1700 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 9529 | 0.010 |
Why?
|
| DNA Primers | 1 | 2002 | 2817 | 0.010 |
Why?
|
| Patient Selection | 1 | 2010 | 4237 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2010 | 10073 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2009 | 4533 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2008 | 2722 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2004 | 20988 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2010 | 5491 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2001 | 1519 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2012 | 4020 | 0.010 |
Why?
|
| Cell Movement | 1 | 2008 | 5200 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2008 | 3045 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2004 | 4110 | 0.010 |
Why?
|
| Disease Progression | 1 | 2012 | 13495 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2001 | 1360 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2007 | 3533 | 0.010 |
Why?
|
| United States | 1 | 2022 | 72272 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2014 | 23972 | 0.010 |
Why?
|
| Genotype | 1 | 2007 | 12978 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 17878 | 0.010 |
Why?
|
| Alleles | 1 | 2002 | 6861 | 0.010 |
Why?
|
| Algorithms | 1 | 2010 | 14018 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 14648 | 0.010 |
Why?
|
| Gene Expression | 1 | 2001 | 7568 | 0.000 |
Why?
|
| Young Adult | 1 | 2015 | 59179 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 2004 | 15251 | 0.000 |
Why?
|
| Longitudinal Studies | 1 | 2004 | 14591 | 0.000 |
Why?
|
| Risk Factors | 1 | 2013 | 74115 | 0.000 |
Why?
|
Concepts
(306)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(46)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_